Table 2.
Molecular defects and recurrence risks in AS
| Genetic defect | Proportion of cases [13] | Recurrence risk |
|---|---|---|
| De novo deletion of 15q11q13 on the maternal chromosome | 75% | <1%a |
| Paternal uniparental disomy (UPD) of chromosome 15 | 1–2% | <1%b |
| Imprinting defect (without an imprinting centre deletion) | 3% | <1% |
| Imprinting centre deletion | ≈10–15% of patients with an imprinting defect | 50% (if present in a non-mosaic state in the mother) |
| UBE3A mutation | 5–10% | 50% (if present in a non-mosaic state in the mother) |
| No identifiable molecular abnormality | 10–15% | Unknown (up to 50%) |
aIf maternal karyotype is normal
bIf parental karyotypes are normal